Shigella flexneri Castellani and Chalmers (ATCC® 25876)

Strain Designations: Mel SmD  /  Type Strain: no  /  Biosafety Level: 2

Permits And Restrictions

View Permits

Strain Designations Mel SmD
Application
Used to produce oral vaccine in Yugoslavia
Enteric Research
Emerging infectious disease research
Isolation
Streptomycin-dependent clone derived from Shigella flexneri (Serotype 2a) ATCC 25875.
Type Strain no
Biosafety Level 2
Antigenic Properties Serotype 2a
Product Format freeze-dried
Preceptrol® no
Type Strain no
Antigenic Properties Serotype 2a
Medium Medium 55: Nutrient agar with dihydrostreptomycin 625 mcg/ml
Growth Conditions
Temperature: 37.0°C
Name of Depositor O Felsenfeld
Chain of Custody
ATCC <<--O Felsenfeld<<--D. Mel
Isolation
Streptomycin-dependent clone derived from Shigella flexneri (Serotype 2a) ATCC 25875.
References

Mel DM, et al. Studies on vaccination against bacillary dysentery. 1. Immunization of mice against experimental Shigella infection. Bull. World Health Organ. 32: 633-636, 1965. PubMed: 5294178

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation